Cargando…

Plasma Neurofilament Light: A Marker of Neurodegeneration in Mild Behavioral Impairment

BACKGROUND: Assessing neuropsychiatric symptoms (NPS) in older adults is important for determining dementia risk. Mild behavioral impairment (MBI) is an at-risk state for cognitive decline and dementia, characterized by emergent NPS in later life. MBI has significantly higher dementia incidence than...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naude, James P., Gill, Sascha, Hu, Sophie, McGirr, Alexander, Forkert, Nils D., Monchi, Oury, Stys, Peter K., Smith, Eric E., Ismail, Zahinoor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504997/ https://www.ncbi.nlm.nih.gov/pubmed/32597801 http://dx.doi.org/10.3233/JAD-200011

Ejemplares similares

Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline
por: Ismail, Zahinoor, et al.
Publicado: (2021)

Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms
por: McGirr, Alexander, et al.
Publicado: (2022)

Modeling Neurodegeneration in silico With Deep Learning
por: Tuladhar, Anup, et al.
Publicado: (2021)

Functional connectivity and mild behavioral impairment in dementia‐free elderly
por: Ghahremani, Maryam, et al.
Publicado: (2023)

Motor symptoms in Parkinson’s disease are related to the interplay between cortical curvature and thickness
por: Almgren, Hannes, et al.
Publicado: (2022)

Machine learning-based prediction of longitudinal cognitive decline in early Parkinson’s disease using multimodal features
por: Almgren, Hannes, et al.
Publicado: (2023)

Explainable classification of Parkinson’s disease using deep learning trained on a large multi-center database of T1-weighted MRI datasets
por: Camacho, Milton, et al.
Publicado: (2023)

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
por: Mattsson, Niklas, et al.
Publicado: (2017)

Screening for neurodegeneration in Langerhans cell histiocytosis with neurofilament light in plasma
por: Sveijer, Malin, et al.
Publicado: (2022)

Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes
por: Marks, Jordan D., et al.
Publicado: (2021)

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
por: Lewczuk, Piotr, et al.
Publicado: (2018)

Neurofilament Light Chain in Aqueous Humor as a Marker of Neurodegeneration in Glaucoma
por: Lin, Jonathan B, et al.
Publicado: (2023)

Neural correlates of the impulse dyscontrol domain of mild behavioral impairment
por: Gill, Sascha, et al.
Publicado: (2021)

Plasma neurofilament light chain as a potential biomarker of neurodegeneration in murine brain
por: Sano, Tomoya, et al.
Publicado: (2023)

Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration
por: Weston, Philip S.J., et al.
Publicado: (2017)

Mild behavioral impairment in Parkinson's disease is associated with altered corticostriatal connectivity
por: Lang, Stefan, et al.
Publicado: (2020)

Apathy and APOE in mild behavioral impairment, and risk for incident dementia
por: Vellone, Daniella, et al.
Publicado: (2022)

Neurofilament light chain plasma concentration predicts neurodegeneration and clinical progression in nondemented elderly adults
por: Hu, Hao, et al.
Publicado: (2019)

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
por: Strydom, Andre, et al.
Publicado: (2018)

Neurofilament Light Chain Is a Biomarker of Neurodegeneration in Ataxia Telangiectasia
por: Donath, H., et al.
Publicado: (2021)

Common and unique connectivity at the interface of motor, neuropsychiatric, and cognitive symptoms in Parkinson's disease: A commonality analysis
por: Lang, Stefan, et al.
Publicado: (2020)

Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
por: Sánchez-Valle, Raquel, et al.
Publicado: (2018)

The effect of lumbar puncture on the neurodegeneration biomarker neurofilament light in macaque monkeys
por: Boehnke, Susan E., et al.
Publicado: (2020)

Uman-type neurofilament light antibodies are effective reagents for the imaging of neurodegeneration
por: Shaw, Gerry, et al.
Publicado: (2023)

Using Machine Learning to Predict Dementia from Neuropsychiatric Symptom and Neuroimaging Data
por: Gill, Sascha, et al.
Publicado: (2020)

Integrating expert knowledge for dementia risk prediction in individuals with mild cognitive impairment (MCI): a study protocol
por: Wang, Meng, et al.
Publicado: (2021)

Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration
por: Ashton, Nicholas J., et al.
Publicado: (2019)

Plasma neurofilament light admission levels and development of axonal pathology in mild traumatic brain injury
por: Hossain, Iftakher, et al.
Publicado: (2023)

Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19
por: Ameres, Markus, et al.
Publicado: (2020)

Structural Neuroimaging Markers of Cognitive Decline in Parkinson's Disease
por: Hanganu, Alexandru, et al.
Publicado: (2016)

Plasma β-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia
por: Rodrigues-Amorim, Daniela, et al.
Publicado: (2020)

Dementia risk prediction in individuals with mild cognitive impairment: a comparison of Cox regression and machine learning models
por: Wang, Meng, et al.
Publicado: (2022)

Image-encoded biological and non-biological variables may be used as shortcuts in deep learning models trained on multisite neuroimaging data
por: Souza, Raissa, et al.
Publicado: (2023)

Plasma neurofilament light in Huntington’s disease: A marker for disease onset, but not symptom progression
por: Parkin, Georgia M., et al.
Publicado: (2021)

Rare PMP22 variants in mild to severe neuropathy uncorrelated to plasma GDF15 or neurofilament light
por: Palu, Edouard, et al.
Publicado: (2023)

Patterns of brain activity during a set-shifting task linked to mild behavioral impairment in Parkinson’s disease
por: Jin Yoon, Eun, et al.
Publicado: (2021)

CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration
por: Pawlitzki, Marc, et al.
Publicado: (2018)

Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer’s disease
por: Andersson, Emelie, et al.
Publicado: (2020)

Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy
por: Weinhofer, Isabelle, et al.
Publicado: (2021)

Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer’s disease
por: Creese, Byron, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dedp4a3vrnfn3vd1ikcnat5kcu